GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for nicotinate-nucleotide-- dimethylbenzimidazole phosphoribosyltransferase (B8I7A3)

Analyse AlphaFold monomer V2.0 prediction for nicotinate-nucleotide… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
B8I7A3
Type
protein
Length
352 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xbDA05C32aD6eE153C8C5A78dfa48d7Ba25694fea
Molecule
Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase
UniProt
B8I7A3
Pockets
2 · best druggability 0.65

Structure

1 distinct chain · 52% helix, 10% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferaseprotein35252% helix, 10% strandB8I7A3

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11790.650.8535empty
2990.380.7616empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.